Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
cancer
5
×
life sciences
national
5
×
national blog main
bristol-myers squibb
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
immunotherapy
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
cancer immunotherapy
celgene
esmo
european society for medical oncology
immuno-oncology
keytruda
What
medical
5
×
clinical
annual
conference
society
acquisition
anniversary
approaches
ash
bn
bristol
cancer
celgene
chief
company’s
corporation
diversity
esmo
european
hirawat
myers
myers’s
officer
oncology
pipeline
progress
scrip
spoke
squibb
trial
year
american
barcelona
blood
borne
breast
cancer's
cancers
data
december's
Language
unset
Current search:
national
×
biotech
×
cancer
×
medical
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front